IL6 and osteoarthritis: Osteoarthritis (OA) is a degenerative musculoskeletal disorder marked by progressive cartilage degradation, synovial inflammation and subchondral bone remodeling, driven by pro-inflammatory mediators such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).